Impacts of long-term treatments with testosterone replacement and pioglitazone on glucose and lipid metabolism in male patients with Werner's syndrome.
Yamamoto
Hiroyasu
H
Kurebayashi
Shogo
S
Kouhara
Haruhiko
H
Yoshiuchi
Kazutomi
K
Matsuhisa
Munehide
M
Yamasaki
Yoshimitsu
Y
Kasayama
Soji
S
D000328:Adult; D001786:Blood Glucose / Q000378:metabolism*; D004359:Drug Therapy, Combination; D005947:Glucose / Q000378:metabolism*; D020249:Hormone Replacement Therapy; D006801:Humans; D007333:Insulin Resistance; D050356:Lipid Metabolism / Q000187:drug effects*; D008297:Male; D000077205:Pioglitazone; D013739:Testosterone / Q000008:administration & dosage* / Q000627:therapeutic use; D045162:Thiazolidinediones / Q000008:administration & dosage* / Q000627:therapeutic use; D016896:Treatment Outcome; D014898:Werner Syndrome / Q000188:drug therapy* / Q000378:metabolism
D001786:Blood Glucose; D045162:Thiazolidinediones; D013739:Testosterone; D005947:Glucose; D000077205:Pioglitazone